FPi is an Egyptian pharma company established by a determined group of partners to be a unique business in Egypt.
After 4 years working in the legislative and the licensing process, FPi has successfully acquired distinguished talents at several levels to derive and deliver organizational KPIs.
Since 2011, more than 30 molecules were launched, and the company has built a pipeline of another 50.
Contact
1st Industrial Zone, 4G, Badr City, Cairo.
+2022864757882
Dr Sherif Rashed, managing partner and chairman of Magicpharma, explains how the company’s unique business model has allowed it to become one of the Top 50 pharmaceutical companies in Egypt…
Dr Wafik Bardissi, chairman and CEO of Minapharm, the only company to offer biosimilars in Egypt, highlights how the company has successfully developed biotech know-how by partnering with and acquiring…
Dr Mohamed Mabrouk, CEO of Pharmed Healthcare, highlights how the company has evolved from only offering Hepatitis C treatment to having 112 products in the pipeline today. He also emphasises…
Ashraf Elkhouly, executive director of the Egyptian Society for Pharmaceutical Research, discusses how recent healthcare reforms will help to attract more investment to Egypt and the importance of public-private partnerships…
Ahmed Elfangary, country manager of DHL Express Egypt, highlights the company’s leadership position in the Egyptian logistics field, while aiming to be a strong partner of the government. He also…
The 100 Million Seha (100 Million healthy lives) campaign, which kicked off on a national scale in October 2018 under the auspices of President Abdel Fattah El-Sisi, aims to detect…
Amro Kandil, managing director of Northeast Africa at GE Healthcare, emphasizes the company’s crucial role in improving healthcare in Egypt as part of a long-standing partnership with the Ministry of…
Ramez Mohsen, managing director at Janssen for Egypt, Jordan, Libya & Sudan, highlights how the company is driving real access to treatments in Egypt through collaboration with various stakeholders. He…
Ashraf Osman, president and CEO of AUG Pharma, explains how his company has become one of Egypt’s Top 30 pharmaceutical companies in less than four years of manufacturing, gives an…
Basyouni Abuseif, country president and CPO Head at Novartis Egypt, explains how the Swiss company has taken over the leadership position in the Egyptian pharmaceutical market despite economic and political…
Dr Maged George, chairman of the Egyptian Export Council of Medical Industries, highlights the obstacles that the Egyptian pharmaceutical industry is facing in the wake of the currency devaluation both…
Christelle Saghbini, the newly appointed chairman & managing director of Sanofi for Egypt & Sudan, highlights her strategic roadmap for bringing access to innovative medicines to Egypt. She also explains…
See our Cookie Privacy Policy Here
